DEF 14AThe Ballot
Niagen Bioscience, Inc. files DEF 14A
Filed Apr 29, 2026 · 2mo ago · Accession 0001386570-26-000022
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Niagen Bioscience, Inc.
- Ticker
- NAGE
- CIK
- 1386570
- Form type
- DEF 14A
- Filing date
- Apr 29, 2026
- Report date
- Jun 24, 2026
- Document
- cdxc-20260429.htm
- Size
- 3.2 MB